financetom
Business
financetom
/
Business
/
US lenders not on insolvency panel of India's Byju's, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US lenders not on insolvency panel of India's Byju's, sources say
Sep 4, 2024 12:31 AM

By Aditya Kalra

NEW DELHI (Reuters) -U.S.-based Glas Trust is not part of a key panel overseeing the insolvency proceedings of Indian education-technology giant Byju's, and will need to substantiate the $1 billion claim of lenders it represents, according to documents and three sources.

Byju's was once a darling of global investors and valued at $22 billion in 2022, but is now facing insolvency due to its dispute with U.S. lenders. The company became popular by offering online training courses during the COVID-19 pandemic.

Its insolvency officer, Pankaj Srivastava, told Glas in a Sept. 1 letter that a majority of the lenders it was representing have no business rights left as part of agreements with Byju's, and can't stake a claim.

As a result, in a setback for U.S. lenders, the insolvency panel has been reconstituted without Glas Trust, according to three sources with direct knowledge of the matter, who spoke on condition of anonymity.

Srivastava has asked Glas to clarify its position and "provide supportive documents," the Sept. 1 letter, which is not public but was reviewed by Reuters, showed.

U.S. term loan lenders in a joint statement early on Wednesday said the decision to exclude Glas Trust from the insolvency panel "is completely wrong in law and in fact."

Srivastava did not respond to a request for comment.

Byju's, started in 2011, has suffered numerous setbacks in recent months, from boardroom exits and criticism over delayed financial disclosures to an auditor resignation.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gilead posts higher profit as HIV sales rise, helped by prevention drugs
Gilead posts higher profit as HIV sales rise, helped by prevention drugs
Oct 30, 2025
Oct 30 (Reuters) - Gilead Sciences ( GILD ) said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for its new prevention drug Yeztugo, helping to boost its profit above Wall Street estimates. Wall Street expected sales of Yeztugo, which has an annual U.S. list price of about $28,000, at...
Vistra Unusual Options Activity
Vistra Unusual Options Activity
Oct 30, 2025
Deep-pocketed investors have adopted a bullish approach towards Vistra ( VST ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in VST usually suggests something big is about to happen. We gleaned this information from...
Dexcom beats quarterly estimates on strong demand for glucose monitors
Dexcom beats quarterly estimates on strong demand for glucose monitors
Oct 30, 2025
Oct 30 (Reuters) - Medical device maker Dexcom ( DXCM ) topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems. Interim CEO Jake Leach said the company's performance was driven by continued expansion of access to the G7 system, which helps people with diabetes track their glucose levels without finger...
Bayer's Monsanto must pay $185 million after state Supreme Court restores chemical leak verdict
Bayer's Monsanto must pay $185 million after state Supreme Court restores chemical leak verdict
Oct 30, 2025
* Washington Supreme Court reinstates $185 million verdict against Monsanto * Lower court had vacated the verdict from the 2021 trial * Monsanto has faced hundreds of claims related to chemical contamination at a Seattle-area school (Adds comment from Monsanto and attorneys for the plaintiffs in paragraphs 5-6, details throughout) By Diana Novak Jones Oct 30 (Reuters) - A U.S....
Copyright 2023-2026 - www.financetom.com All Rights Reserved